Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Recruiting
Observational Study
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is being done to find out if patient blood samples can be used to perform individualized modeling of cancer therapy-related side effects.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Any patient \>= 18 years of age
* Previously treated, planned or currently receiving any potentially toxic cancer therapy including but not limited to chemotherapy, targeted and immunotherapies
Exclusion Criteria:
* Inability on the part of the patient to understand the info…
Contacts